FDA Clears Toshiba's Interventional Lab-CT Solution

March 20, 2015 - Toshiba America Medical Systems combines interventional labs and CT technology and receives in its new Infinix™ 4DCT and received FDA clearance with the Aquilion™ PRIME CT system configuration. 

Toshiba’s Infinix 4DCT is an all-in-one interventional lab and CT solution designed to deliver real-time CT images during procedures instead of CT-like images. The system significantly improves workflow with its SUREGuidance technology, which allows for automatic transition between modalities. In addition, it is capable of saving significant time by allowing clinicians to perform CT and interventional procedures within the same room and verify treatment success following procedures.
Clinically, the Infinix 4DCT maximizes workflow of oncology and cardiac procedures, as it provides interventionalists with CT images for the target anatomy. Clinicians now have the ability to adjust the procedure with real-time CT studies, instead of relying on CT images taken at an earlier time.

“The Infinix 4DCT allows clinicians to plan, treat and verify in a single clinical setting, which negates the need to transfer patients between departments, resulting in anticipated decreases of both procedure time and risk of infection,” said Bill Newsom, director, X-ray Vascular Business Unit, Toshiba. “This also contributes to improved patient safety and satisfaction by minimizing the clinicians’ time spent away from patients, allowing them to focus on providing quality care.”

The Infinix 4DCT previously received FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion ONE ViSION Edition CT system configuration. Toshiba will showcase the Infinix 4DCT with the Aquilion PRIME CT at this year’s American College of Cardiology (ACC) annual meeting in San Diego, March 14-16, 2015 (Booth #1916).